U
CVR PARTNERS, LP
UANCIK 0001425292NYSEAcceleratedAgricultural ChemicalsDelawareFY ends Dec 31
Period
FY 2025
Revenue
$606.04M
Net Income
$98.66M
Total Assets
$969.46M
Equity
—
Shares Out
10.57M
Op. Cash Flow
$149.64M
Business
CVR PARTNERS, LP produces and distributes nitrogen fertilizer products for agricultural and industrial customers. Its primary products include ammonia, urea ammonium nitrate (UAN), and nitric acid, marketed on a wholesale basis. The Partnership operates through two manufacturing subsidiaries that run the Coffeyville and East Dubuque facilities, each with distinct feedstock and product-upgrade capabilities and supporting subsidiaries responsible for operations. CVR Partners sells primarily within the United States through rail, truck, and barge distribution channels, with significant regional sales proximate to its facilities.
Summary from filing dated 2025-02-19
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net sales | 606 | 525 | 681 | 836 | 533 | |
| Cost of materials and other | 107 | 104 | 134 | 131 | 98 | |
| Direct operating expenses (exclusive of depreciation and amortization) | 254 | 214 | 235 | 270 | 199 | |
| Depreciation and amortization | 82 | 88 | 80 | 82 | 73 | |
| Cost of sales | 443 | 406 | 449 | 483 | 371 | |
| Selling, general and administrative expenses | 34 | 28 | 30 | 32 | 27 | |
| Loss on asset disposals | 1 | 100,000 | 2 | 263,000 | 948,000 | |
| Operating income | 129 | 90 | 201 | 320 | 134 | |
| Interest expense, net | −30 | −30 | −29 | −34 | — | |
| Other income (expense), net | 326,000 | 453,000 | −33,000 | 1 | 5 | |
| Income before income taxes | 99 | 61 | 173 | 287 | 78 | |
| Income tax (benefit) expense | −23,000 | 77,000 | 289,000 | 160,000 | 57,000 | |
| Net income | 99 | 61 | 172 | 287 | 78 | |
| Basic earnings per common unit (in dollars per unit) | 9.33 | 5.76 | 16.31 | 27.07 | 7.31 | |
| Diluted earnings per common unit (in dollars per unit) | 9.33 | 5.76 | 16.31 | 27.07 | 7.31 | |
| Basic (in units) | 11 | 11 | 11 | 11 | 11 | |
| Diluted (in units) | 11 | 11 | 11 | 11 | 11 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 69 | 91 | 45 | 86 | 113 | |
| Accounts receivable, net | 59 | 65 | 42 | 90 | 88 | |
| Inventories | 83 | 76 | 69 | 78 | 52 | |
| Prepaid expenses | 1 | 1 | 8 | — | — | |
| Other current assets | 1 | 632,000 | 1 | — | — | |
| Total current assets | 214 | 234 | 166 | 266 | 262 | |
| Property, plant and equipment, net | 712 | 736 | 761 | — | — | |
| Other long-term assets | 44 | 50 | 48 | 24 | 14 | |
| Total assets | 969 | 1,019 | 975 | 1,100 | 1,127 | |
| Deferred revenue | 23 | 51 | 16 | 48 | 87 | |
| Other current liabilities | 25 | 24 | 21 | 28 | 24 | |
| Total current liabilities | 97 | 111 | 75 | 126 | 162 | |
| Long-term debt and finance lease obligations, net of current portion | 569 | 568 | 547 | — | — | |
| Long-term deferred revenue | 21 | 27 | 33 | 0 | — | |
| Other long-term liabilities | 17 | 19 | 16 | 16 | 12 | |
| Total long-term liabilities | 607 | 614 | 597 | 563 | 623 | |
| Commitments and contingencies (See Note 11) | — | — | — | — | — | |
| Common unitholders, 10,569,637 and 10,569,637 units issued and outstanding as of December 31, 2025 and 2024, respectively | 266 | 293 | 303 | 412 | 342 | |
| General partner interest | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | |
| Total partners capital | 266 | 293 | 303 | 412 | 342 | |
| Total liabilities and partners capital | 969 | 1,019 | 975 | 1,100 | 1,127 |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Amortization of deferred financing costs and original issue discount | 730,000 | 696,000 | 754,000 | 821,000 | 3 | |
| Loss on asset disposals | 1 | 100,000 | 2 | 263,000 | 948,000 | |
| Share-based compensation | 10 | 5 | 8 | 25 | 23 | |
| Other adjustments | −65,000 | 76,000 | 222,000 | −107,000 | 142,000 | |
| Accounts receivable | 6 | −23 | 28 | −21 | −22 | |
| Inventories | −8 | −6 | 7 | −25 | −8 | |
| Prepaid expenses and other current assets | −673,000 | 2 | 1 | −2 | −785,000 | |
| Accounts payable | 6 | −6 | −24 | −7 | 11 | |
| Deferred revenue | −34 | 29 | −23 | −21 | 27 | |
| Other current liabilities | −12 | 13,000 | −8 | −15 | — | |
| Net cash provided by operating activities | 150 | 151 | 244 | 301 | 189 | |
| Capital expenditures | −51 | −37 | −24 | −45 | −21 | |
| Proceeds from the sale of assets | 54,000 | 4,000 | 0 | 45,000 | 252,000 | |
| Return of equity method investment | 7 | 5 | 21 | 0 | 0 | |
| Net cash used in investing activities | −44 | −32 | −3 | −45 | −20 | |
| Cash distributions to common unitholders | −126 | −71 | −281 | −205 | — | |
| Other financing activities | −1 | −2 | −500,000 | −1,000 | −96,000 | |
| Net cash used in financing activities | −127 | −73 | −282 | −283 | −86 | |
| Net (decrease) increase in cash and cash equivalents | −22 | 46 | −41 | −26 | 82 |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro